| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcus pyogenes | 58 | 2023 | 293 | 13.000 |
Why?
|
| Streptococcal Infections | 48 | 2022 | 619 | 5.340 |
Why?
|
| Streptococcus agalactiae | 51 | 2022 | 337 | 5.000 |
Why?
|
| NAD+ Nucleosidase | 11 | 2023 | 43 | 4.050 |
Why?
|
| Streptolysins | 19 | 2021 | 61 | 3.950 |
Why?
|
| Bacterial Proteins | 49 | 2023 | 3840 | 3.380 |
Why?
|
| Gene Expression Regulation, Bacterial | 21 | 2021 | 1137 | 3.120 |
Why?
|
| Polysaccharides, Bacterial | 39 | 2019 | 582 | 2.730 |
Why?
|
| Bacterial Capsules | 25 | 2019 | 247 | 2.450 |
Why?
|
| Hyaluronic Acid | 19 | 2019 | 488 | 1.940 |
Why?
|
| Protein Kinases | 8 | 2021 | 1611 | 1.930 |
Why?
|
| Keratinocytes | 16 | 2021 | 876 | 1.660 |
Why?
|
| Virulence | 33 | 2021 | 1298 | 1.530 |
Why?
|
| Bacterial Adhesion | 8 | 2021 | 305 | 1.500 |
Why?
|
| Bacterial Outer Membrane Proteins | 9 | 2019 | 404 | 1.330 |
Why?
|
| Regulon | 3 | 2021 | 71 | 1.310 |
Why?
|
| Antigens, Bacterial | 15 | 2019 | 1150 | 1.260 |
Why?
|
| Cathelicidins | 5 | 2021 | 81 | 1.240 |
Why?
|
| Virulence Factors | 8 | 2019 | 502 | 1.040 |
Why?
|
| Genes, Bacterial | 17 | 2007 | 1076 | 0.960 |
Why?
|
| Adhesins, Bacterial | 3 | 2013 | 118 | 0.860 |
Why?
|
| Pharyngitis | 5 | 2013 | 222 | 0.860 |
Why?
|
| Repressor Proteins | 5 | 2021 | 2986 | 0.840 |
Why?
|
| Oropharynx | 2 | 2021 | 139 | 0.780 |
Why?
|
| DNA Restriction-Modification Enzymes | 1 | 2021 | 11 | 0.760 |
Why?
|
| Transformation, Genetic | 1 | 2021 | 194 | 0.730 |
Why?
|
| Antimicrobial Cationic Peptides | 5 | 2021 | 353 | 0.690 |
Why?
|
| Antibodies, Bacterial | 16 | 2000 | 1478 | 0.690 |
Why?
|
| Carrier Proteins | 11 | 2019 | 4939 | 0.680 |
Why?
|
| Bacterial Vaccines | 11 | 1999 | 400 | 0.660 |
Why?
|
| Bacterial Toxins | 9 | 2021 | 922 | 0.660 |
Why?
|
| NAD | 2 | 2022 | 618 | 0.660 |
Why?
|
| Phagocytosis | 25 | 2014 | 1530 | 0.660 |
Why?
|
| Tetanus Toxoid | 9 | 1999 | 189 | 0.590 |
Why?
|
| Epithelial Cells | 6 | 2016 | 3702 | 0.550 |
Why?
|
| Magnesium | 3 | 2021 | 816 | 0.530 |
Why?
|
| Operon | 5 | 2017 | 371 | 0.520 |
Why?
|
| Clindamycin | 4 | 2015 | 138 | 0.510 |
Why?
|
| Pharynx | 6 | 2013 | 436 | 0.510 |
Why?
|
| Skin Diseases, Bacterial | 2 | 2015 | 65 | 0.500 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2015 | 39 | 0.470 |
Why?
|
| Whooping Cough | 1 | 2015 | 87 | 0.460 |
Why?
|
| Opsonin Proteins | 8 | 1999 | 144 | 0.450 |
Why?
|
| Cellulitis | 2 | 2015 | 206 | 0.440 |
Why?
|
| Azithromycin | 1 | 2015 | 201 | 0.440 |
Why?
|
| Phagosomes | 1 | 2014 | 198 | 0.430 |
Why?
|
| Bacteremia | 4 | 2015 | 985 | 0.420 |
Why?
|
| Abscess | 2 | 2015 | 606 | 0.400 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2006 | 4356 | 0.380 |
Why?
|
| Microbial Viability | 2 | 2013 | 237 | 0.380 |
Why?
|
| Penicillin G | 1 | 2011 | 40 | 0.370 |
Why?
|
| Cough | 1 | 2015 | 598 | 0.360 |
Why?
|
| Exotoxins | 3 | 2016 | 123 | 0.340 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2015 | 641 | 0.330 |
Why?
|
| Trans-Activators | 1 | 2019 | 2858 | 0.330 |
Why?
|
| Cytotoxins | 2 | 2022 | 154 | 0.330 |
Why?
|
| Clathrin | 1 | 2011 | 258 | 0.330 |
Why?
|
| Macrophages | 7 | 2023 | 5801 | 0.330 |
Why?
|
| Anti-Bacterial Agents | 9 | 2022 | 7478 | 0.320 |
Why?
|
| Fetal Blood | 2 | 2006 | 1361 | 0.310 |
Why?
|
| Fasciitis, Necrotizing | 4 | 2018 | 79 | 0.300 |
Why?
|
| Complement C3 | 5 | 2003 | 434 | 0.300 |
Why?
|
| Protein Binding | 6 | 2021 | 9344 | 0.290 |
Why?
|
| Molecular Sequence Data | 24 | 2014 | 17629 | 0.290 |
Why?
|
| Complement System Proteins | 2 | 2003 | 738 | 0.290 |
Why?
|
| Monocytes | 3 | 2006 | 2603 | 0.280 |
Why?
|
| Toll-Like Receptors | 4 | 2006 | 582 | 0.280 |
Why?
|
| Receptor, Adenosine A3 | 1 | 2006 | 4 | 0.280 |
Why?
|
| Cell Line | 8 | 2021 | 15604 | 0.270 |
Why?
|
| Transferases | 2 | 1998 | 71 | 0.270 |
Why?
|
| Carbohydrate Sequence | 13 | 2005 | 411 | 0.270 |
Why?
|
| Glycosyltransferases | 2 | 1998 | 114 | 0.260 |
Why?
|
| Protein Transport | 3 | 2021 | 1956 | 0.260 |
Why?
|
| Rheumatic Fever | 1 | 2006 | 73 | 0.250 |
Why?
|
| Lysosomes | 2 | 2016 | 940 | 0.250 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2006 | 98 | 0.250 |
Why?
|
| Cells, Cultured | 11 | 2019 | 19023 | 0.250 |
Why?
|
| Disease Outbreaks | 1 | 2015 | 1761 | 0.250 |
Why?
|
| Autophagy | 1 | 2013 | 1351 | 0.240 |
Why?
|
| Phosphorylation | 5 | 2021 | 8317 | 0.240 |
Why?
|
| Promoter Regions, Genetic | 4 | 2021 | 5801 | 0.240 |
Why?
|
| Aminoquinolines | 1 | 2004 | 105 | 0.230 |
Why?
|
| Serotyping | 8 | 2006 | 331 | 0.230 |
Why?
|
| Humans | 84 | 2024 | 768970 | 0.220 |
Why?
|
| Immunoglobulin G | 9 | 2006 | 4568 | 0.220 |
Why?
|
| Models, Molecular | 4 | 2021 | 5404 | 0.220 |
Why?
|
| Down-Regulation | 1 | 2011 | 2942 | 0.220 |
Why?
|
| Oligosaccharides | 5 | 1995 | 407 | 0.220 |
Why?
|
| Xenopus Proteins | 2 | 1998 | 435 | 0.220 |
Why?
|
| Sialic Acids | 4 | 1994 | 123 | 0.210 |
Why?
|
| Lipoproteins | 2 | 2006 | 880 | 0.210 |
Why?
|
| Dextran Sulfate | 1 | 2024 | 258 | 0.210 |
Why?
|
| Intracellular Membranes | 2 | 2014 | 388 | 0.210 |
Why?
|
| Bacteroides fragilis | 1 | 2024 | 250 | 0.200 |
Why?
|
| Streptococcus | 2 | 1997 | 198 | 0.200 |
Why?
|
| Plasmids | 6 | 2007 | 2269 | 0.200 |
Why?
|
| Antigen-Presenting Cells | 1 | 2006 | 962 | 0.200 |
Why?
|
| Sphingolipids | 1 | 2024 | 178 | 0.200 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2012 | 2488 | 0.200 |
Why?
|
| Membrane Glycoproteins | 3 | 2004 | 3713 | 0.200 |
Why?
|
| Haemophilus influenzae | 1 | 2022 | 177 | 0.200 |
Why?
|
| Interleukin-1beta | 2 | 2019 | 1026 | 0.200 |
Why?
|
| Meningitis, Bacterial | 2 | 2022 | 225 | 0.190 |
Why?
|
| Signal Transduction | 5 | 2018 | 23653 | 0.190 |
Why?
|
| Lipopolysaccharides | 4 | 2006 | 2222 | 0.190 |
Why?
|
| Ehrlichia chaffeensis | 1 | 2000 | 3 | 0.190 |
Why?
|
| Cloning, Molecular | 6 | 2014 | 4168 | 0.190 |
Why?
|
| Adjuvants, Immunologic | 1 | 2006 | 999 | 0.180 |
Why?
|
| Ehrlichiosis | 1 | 2000 | 28 | 0.180 |
Why?
|
| Cytosol | 2 | 2014 | 886 | 0.180 |
Why?
|
| Calcium Signaling | 1 | 2005 | 738 | 0.180 |
Why?
|
| Glucuronosyltransferase | 2 | 1998 | 136 | 0.170 |
Why?
|
| Vaccines, Conjugate | 8 | 1999 | 334 | 0.160 |
Why?
|
| Membrane Proteins | 4 | 2013 | 7885 | 0.160 |
Why?
|
| Cell Wall | 2 | 2000 | 421 | 0.160 |
Why?
|
| Complement C1q | 1 | 1999 | 93 | 0.160 |
Why?
|
| Vacuoles | 2 | 2013 | 224 | 0.160 |
Why?
|
| Interleukins | 1 | 2024 | 796 | 0.160 |
Why?
|
| MAP Kinase Signaling System | 1 | 2006 | 1495 | 0.160 |
Why?
|
| Uridine Diphosphate Glucose Dehydrogenase | 1 | 1998 | 8 | 0.160 |
Why?
|
| Cysteine Endopeptidases | 1 | 2001 | 542 | 0.160 |
Why?
|
| Glucuronic Acid | 1 | 2019 | 150 | 0.160 |
Why?
|
| Vitamin D | 1 | 2012 | 3311 | 0.160 |
Why?
|
| N-Acylneuraminate Cytidylyltransferase | 2 | 1996 | 7 | 0.160 |
Why?
|
| Multigene Family | 2 | 2005 | 1082 | 0.160 |
Why?
|
| Imidazoles | 1 | 2004 | 1169 | 0.150 |
Why?
|
| Biofilms | 2 | 2013 | 634 | 0.150 |
Why?
|
| Mutagenesis, Insertional | 3 | 1998 | 662 | 0.150 |
Why?
|
| Mice, Inbred ICR | 4 | 2005 | 363 | 0.150 |
Why?
|
| Animals | 44 | 2024 | 169335 | 0.150 |
Why?
|
| Dendritic Cells | 1 | 2009 | 2748 | 0.150 |
Why?
|
| Neutrophils | 6 | 2018 | 3785 | 0.150 |
Why?
|
| Mutation | 14 | 2021 | 30266 | 0.150 |
Why?
|
| Peptidoglycan | 1 | 2000 | 246 | 0.150 |
Why?
|
| Receptors, Cell Surface | 2 | 2004 | 2820 | 0.150 |
Why?
|
| Up-Regulation | 3 | 2014 | 4148 | 0.150 |
Why?
|
| Glycoside Hydrolases | 2 | 1990 | 135 | 0.150 |
Why?
|
| Streptococcal Vaccines | 2 | 2009 | 46 | 0.140 |
Why?
|
| Amino Acid Sequence | 9 | 2014 | 13427 | 0.140 |
Why?
|
| Mice | 30 | 2024 | 82072 | 0.140 |
Why?
|
| Rabbits | 13 | 1999 | 4774 | 0.140 |
Why?
|
| Acetylglucosamine | 1 | 2019 | 189 | 0.140 |
Why?
|
| Base Sequence | 11 | 2005 | 12430 | 0.140 |
Why?
|
| Cell Survival | 3 | 2016 | 5793 | 0.140 |
Why?
|
| Amino Acid Substitution | 1 | 2021 | 1742 | 0.140 |
Why?
|
| Immunologic Factors | 1 | 2006 | 1597 | 0.140 |
Why?
|
| Open Reading Frames | 3 | 2013 | 818 | 0.140 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2019 | 450 | 0.140 |
Why?
|
| Chromosomes, Bacterial | 2 | 1995 | 281 | 0.140 |
Why?
|
| Facial Paralysis | 1 | 2000 | 346 | 0.130 |
Why?
|
| Receptors, Complement | 1 | 1997 | 254 | 0.130 |
Why?
|
| Host-Pathogen Interactions | 2 | 2017 | 1469 | 0.130 |
Why?
|
| Glycolipids | 1 | 1997 | 205 | 0.130 |
Why?
|
| IMP Dehydrogenase | 1 | 1995 | 34 | 0.130 |
Why?
|
| Inflammasomes | 2 | 2019 | 540 | 0.130 |
Why?
|
| Protein Stability | 1 | 2017 | 580 | 0.130 |
Why?
|
| Mutagenesis | 3 | 2012 | 1229 | 0.130 |
Why?
|
| Recombinant Proteins | 3 | 2016 | 6512 | 0.120 |
Why?
|
| Colitis | 1 | 2024 | 1242 | 0.120 |
Why?
|
| Immune Tolerance | 1 | 2004 | 2323 | 0.120 |
Why?
|
| Culture Media | 1 | 2017 | 898 | 0.120 |
Why?
|
| Complement C4 | 1 | 1995 | 216 | 0.120 |
Why?
|
| Extracellular Matrix | 2 | 2013 | 1739 | 0.120 |
Why?
|
| Intracellular Space | 1 | 2016 | 199 | 0.120 |
Why?
|
| Hemolysis | 3 | 2006 | 417 | 0.120 |
Why?
|
| Apoptosis | 3 | 2005 | 9527 | 0.120 |
Why?
|
| Adaptation, Physiological | 1 | 2021 | 1313 | 0.120 |
Why?
|
| Protein Multimerization | 1 | 2019 | 968 | 0.110 |
Why?
|
| Lactococcus lactis | 1 | 2013 | 28 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 7 | 2006 | 3813 | 0.110 |
Why?
|
| Protein Conformation | 1 | 2021 | 3956 | 0.110 |
Why?
|
| Microscopy, Confocal | 2 | 2014 | 1973 | 0.110 |
Why?
|
| Ubiquitination | 2 | 2019 | 1010 | 0.110 |
Why?
|
| DNA Primers | 4 | 2006 | 2827 | 0.100 |
Why?
|
| Escherichia coli | 6 | 2006 | 4213 | 0.100 |
Why?
|
| Point Mutation | 1 | 2017 | 1596 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2006 | 693 | 0.100 |
Why?
|
| Calcium | 1 | 2005 | 5792 | 0.100 |
Why?
|
| Cell Line, Transformed | 1 | 2013 | 867 | 0.100 |
Why?
|
| Genetic Loci | 1 | 2021 | 2630 | 0.100 |
Why?
|
| Fimbriae, Bacterial | 1 | 2012 | 138 | 0.100 |
Why?
|
| Epitopes | 4 | 1998 | 2529 | 0.090 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1995 | 567 | 0.090 |
Why?
|
| DNA, Bacterial | 5 | 2000 | 1478 | 0.090 |
Why?
|
| Galactosyltransferases | 1 | 1993 | 284 | 0.090 |
Why?
|
| Immunotoxins | 1 | 1992 | 175 | 0.090 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 2 | 2003 | 221 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 3 | 2006 | 2635 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 4 | 2003 | 6086 | 0.090 |
Why?
|
| Immunity, Maternally-Acquired | 3 | 1995 | 112 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2008 | 3810 | 0.090 |
Why?
|
| Dynamins | 1 | 2011 | 141 | 0.090 |
Why?
|
| Fibronectins | 1 | 2013 | 724 | 0.090 |
Why?
|
| Chromosome Deletion | 1 | 1994 | 1390 | 0.080 |
Why?
|
| Premedication | 1 | 1990 | 246 | 0.080 |
Why?
|
| Disease Susceptibility | 3 | 2008 | 1794 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2008 | 294 | 0.080 |
Why?
|
| Immunity | 1 | 1995 | 1003 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 4592 | 0.080 |
Why?
|
| Pneumococcal Infections | 2 | 2005 | 529 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2006 | 1855 | 0.080 |
Why?
|
| DNA Transposable Elements | 6 | 1994 | 764 | 0.080 |
Why?
|
| Papio | 2 | 2001 | 672 | 0.080 |
Why?
|
| Carbohydrate Conformation | 5 | 1991 | 206 | 0.080 |
Why?
|
| Immunodiffusion | 5 | 1996 | 141 | 0.080 |
Why?
|
| Gene Expression Profiling | 4 | 2009 | 9549 | 0.080 |
Why?
|
| Genome, Bacterial | 2 | 2005 | 796 | 0.080 |
Why?
|
| Chromosome Mapping | 4 | 1996 | 4625 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2008 | 12174 | 0.080 |
Why?
|
| Macrophage-1 Antigen | 2 | 2003 | 286 | 0.080 |
Why?
|
| Molecular Weight | 4 | 1998 | 2173 | 0.080 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 1750 | 0.080 |
Why?
|
| Complement Pathway, Classical | 2 | 1999 | 91 | 0.080 |
Why?
|
| Indicators and Reagents | 3 | 2001 | 455 | 0.080 |
Why?
|
| Genetic Complementation Test | 2 | 2007 | 557 | 0.070 |
Why?
|
| Skin Diseases | 1 | 1996 | 1085 | 0.070 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2014 | 1967 | 0.070 |
Why?
|
| Streptococcus pneumoniae | 3 | 2005 | 764 | 0.070 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1987 | 342 | 0.070 |
Why?
|
| Carbohydrate Metabolism | 1 | 2008 | 262 | 0.070 |
Why?
|
| Sequence Analysis | 2 | 2000 | 240 | 0.070 |
Why?
|
| Kinetics | 3 | 2003 | 6332 | 0.070 |
Why?
|
| HeLa Cells | 1 | 2013 | 3076 | 0.070 |
Why?
|
| Adenosine A3 Receptor Antagonists | 1 | 2006 | 2 | 0.070 |
Why?
|
| Infant, Newborn | 5 | 2006 | 26428 | 0.070 |
Why?
|
| Immunity, Innate | 3 | 2006 | 3080 | 0.070 |
Why?
|
| Medical Staff, Hospital | 1 | 1990 | 603 | 0.070 |
Why?
|
| Octoxynol | 1 | 2006 | 76 | 0.070 |
Why?
|
| Lipopeptides | 1 | 2006 | 71 | 0.070 |
Why?
|
| Interleukin-6 | 2 | 2006 | 3232 | 0.070 |
Why?
|
| N-Acetylneuraminic Acid | 4 | 1996 | 175 | 0.060 |
Why?
|
| Genes, Reporter | 2 | 2001 | 1524 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2001 | 3782 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 5 | 2024 | 22379 | 0.060 |
Why?
|
| Female | 27 | 2018 | 397515 | 0.060 |
Why?
|
| I-kappa B Proteins | 1 | 2006 | 210 | 0.060 |
Why?
|
| Leukocytes | 2 | 2008 | 2034 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2006 | 1731 | 0.060 |
Why?
|
| Interferon Inducers | 1 | 2004 | 24 | 0.060 |
Why?
|
| Complement Inactivator Proteins | 1 | 2004 | 74 | 0.060 |
Why?
|
| DNA Fragmentation | 1 | 2005 | 240 | 0.060 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2006 | 169 | 0.060 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 18354 | 0.060 |
Why?
|
| Chromatography, Affinity | 1 | 2006 | 525 | 0.060 |
Why?
|
| Microscopy, Electron | 3 | 1997 | 2560 | 0.060 |
Why?
|
| Ligands | 2 | 2004 | 3283 | 0.060 |
Why?
|
| Complement Factor H | 1 | 2004 | 110 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 612 | 0.060 |
Why?
|
| Adenosine Deaminase | 1 | 2006 | 253 | 0.060 |
Why?
|
| Blood Bactericidal Activity | 2 | 1996 | 124 | 0.060 |
Why?
|
| Integrin alphaXbeta2 | 1 | 2003 | 29 | 0.060 |
Why?
|
| Complement Factor B | 1 | 2003 | 57 | 0.060 |
Why?
|
| Cell Membrane | 2 | 2004 | 3659 | 0.060 |
Why?
|
| Exocytosis | 1 | 2005 | 323 | 0.050 |
Why?
|
| Magnesium Chloride | 1 | 2003 | 30 | 0.050 |
Why?
|
| Boron Compounds | 1 | 2005 | 196 | 0.050 |
Why?
|
| Sequence Deletion | 2 | 2001 | 1498 | 0.050 |
Why?
|
| Hand | 1 | 2009 | 913 | 0.050 |
Why?
|
| Macrophage Activation | 1 | 2006 | 556 | 0.050 |
Why?
|
| Immune Sera | 3 | 1994 | 605 | 0.050 |
Why?
|
| Infection Control | 1 | 1990 | 985 | 0.050 |
Why?
|
| Permeability | 1 | 2005 | 726 | 0.050 |
Why?
|
| Pneumonia | 1 | 2015 | 2164 | 0.050 |
Why?
|
| Cations, Divalent | 1 | 2003 | 167 | 0.050 |
Why?
|
| Blotting, Southern | 3 | 1992 | 777 | 0.050 |
Why?
|
| Serum | 1 | 2003 | 207 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2006 | 1469 | 0.050 |
Why?
|
| Shock, Septic | 1 | 2009 | 774 | 0.050 |
Why?
|
| Liposomes | 1 | 2006 | 793 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2015 | 13021 | 0.050 |
Why?
|
| Immunity, Mucosal | 1 | 2005 | 498 | 0.050 |
Why?
|
| Adenosine | 1 | 2006 | 822 | 0.050 |
Why?
|
| Animals, Newborn | 3 | 1995 | 2683 | 0.050 |
Why?
|
| Intercellular Junctions | 1 | 2001 | 198 | 0.050 |
Why?
|
| Protein Folding | 1 | 2005 | 871 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2006 | 1194 | 0.050 |
Why?
|
| Molecular Mimicry | 1 | 2001 | 213 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2005 | 1505 | 0.040 |
Why?
|
| Twins, Monozygotic | 1 | 2022 | 472 | 0.040 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2001 | 246 | 0.040 |
Why?
|
| Phenotype | 4 | 2011 | 16731 | 0.040 |
Why?
|
| Peritoneum | 1 | 2001 | 231 | 0.040 |
Why?
|
| Acetylglucosaminidase | 1 | 2000 | 66 | 0.040 |
Why?
|
| Biopolymers | 1 | 2001 | 183 | 0.040 |
Why?
|
| HL-60 Cells | 1 | 2000 | 364 | 0.040 |
Why?
|
| Collectins | 1 | 1999 | 18 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2024 | 874 | 0.040 |
Why?
|
| Gene Deletion | 3 | 2009 | 2674 | 0.040 |
Why?
|
| Transduction, Genetic | 2 | 1994 | 902 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 1246 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2006 | 2003 | 0.040 |
Why?
|
| Male | 11 | 2018 | 365203 | 0.040 |
Why?
|
| Mannans | 1 | 1999 | 58 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2000 | 354 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2004 | 1191 | 0.040 |
Why?
|
| Receptors, Adrenergic | 1 | 1979 | 155 | 0.040 |
Why?
|
| Glycoconjugates | 1 | 1999 | 88 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2005 | 1133 | 0.040 |
Why?
|
| General Surgery | 1 | 1990 | 1722 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 3775 | 0.040 |
Why?
|
| Bacterial Infections | 2 | 2006 | 1397 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2001 | 839 | 0.040 |
Why?
|
| Neurons | 1 | 2018 | 9519 | 0.040 |
Why?
|
| Granulocytes | 1 | 2000 | 551 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1979 | 243 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2006 | 5033 | 0.040 |
Why?
|
| Mice, Inbred Strains | 2 | 2005 | 1769 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2006 | 1966 | 0.040 |
Why?
|
| Immunization | 2 | 1994 | 1220 | 0.040 |
Why?
|
| Adult | 12 | 2009 | 223851 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 2005 | 7609 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2008 | 1960 | 0.040 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1979 | 347 | 0.040 |
Why?
|
| Genetic Vectors | 2 | 1998 | 3412 | 0.040 |
Why?
|
| Solubility | 1 | 1999 | 1087 | 0.040 |
Why?
|
| Diterpenes | 1 | 2018 | 170 | 0.040 |
Why?
|
| Lectins | 1 | 1999 | 490 | 0.040 |
Why?
|
| Caspase 1 | 1 | 2018 | 227 | 0.040 |
Why?
|
| Artificial Gene Fusion | 1 | 1997 | 56 | 0.040 |
Why?
|
| Drug Utilization | 3 | 1993 | 1191 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2008 | 3139 | 0.040 |
Why?
|
| Genetic Variation | 3 | 2005 | 6611 | 0.030 |
Why?
|
| Chromatography, Thin Layer | 1 | 1997 | 212 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2004 | 2202 | 0.030 |
Why?
|
| beta-Galactosidase | 2 | 1990 | 575 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2001 | 1179 | 0.030 |
Why?
|
| TRPV Cation Channels | 1 | 2018 | 244 | 0.030 |
Why?
|
| Endopeptidases | 1 | 2000 | 764 | 0.030 |
Why?
|
| Skin | 2 | 2018 | 4506 | 0.030 |
Why?
|
| Immunity, Active | 1 | 1995 | 58 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2001 | 2067 | 0.030 |
Why?
|
| Child | 5 | 2015 | 80960 | 0.030 |
Why?
|
| Galactose | 1 | 1997 | 300 | 0.030 |
Why?
|
| Sequence Alignment | 2 | 2005 | 2179 | 0.030 |
Why?
|
| Binding, Competitive | 3 | 1989 | 1142 | 0.030 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2018 | 328 | 0.030 |
Why?
|
| Cytidine Triphosphate | 1 | 1994 | 17 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 17173 | 0.030 |
Why?
|
| Acute Disease | 1 | 2006 | 7245 | 0.030 |
Why?
|
| Infant | 5 | 2022 | 36556 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2006 | 2682 | 0.030 |
Why?
|
| Monosaccharides | 1 | 1995 | 64 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 1995 | 323 | 0.030 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2018 | 238 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2008 | 3270 | 0.030 |
Why?
|
| Genes, Synthetic | 1 | 1994 | 88 | 0.030 |
Why?
|
| Neisseria meningitidis | 1 | 1994 | 111 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2003 | 5906 | 0.030 |
Why?
|
| Immunization Schedule | 1 | 1995 | 228 | 0.030 |
Why?
|
| Immune Evasion | 1 | 2017 | 376 | 0.030 |
Why?
|
| Connective Tissue Diseases | 1 | 1997 | 285 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 10765 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 7460 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2003 | 1712 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1994 | 849 | 0.030 |
Why?
|
| Time Factors | 3 | 2006 | 40261 | 0.030 |
Why?
|
| Receptors, Complement 3b | 1 | 1993 | 136 | 0.030 |
Why?
|
| Developing Countries | 1 | 2006 | 2911 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2019 | 14484 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2024 | 3044 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 3744 | 0.030 |
Why?
|
| Fibrinogen | 1 | 1996 | 892 | 0.030 |
Why?
|
| Phylogeny | 3 | 2005 | 2843 | 0.030 |
Why?
|
| Drug Prescriptions | 2 | 1993 | 1673 | 0.030 |
Why?
|
| Antibody Affinity | 2 | 1996 | 253 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2001 | 2433 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2022 | 1924 | 0.030 |
Why?
|
| Neuraminidase | 1 | 1992 | 196 | 0.020 |
Why?
|
| Pharmacy Service, Hospital | 1 | 1993 | 134 | 0.020 |
Why?
|
| Immunization, Passive | 2 | 1992 | 619 | 0.020 |
Why?
|
| Immunotherapy, Active | 1 | 1992 | 58 | 0.020 |
Why?
|
| Mitochondria | 1 | 2005 | 3682 | 0.020 |
Why?
|
| Binding Sites, Antibody | 2 | 1989 | 340 | 0.020 |
Why?
|
| Adolescent | 4 | 2015 | 89244 | 0.020 |
Why?
|
| Collagen | 1 | 1999 | 2646 | 0.020 |
Why?
|
| Cefoxitin | 1 | 1990 | 36 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 1997 | 980 | 0.020 |
Why?
|
| Transfection | 1 | 1998 | 5763 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2006 | 10486 | 0.020 |
Why?
|
| Reminder Systems | 1 | 1993 | 388 | 0.020 |
Why?
|
| Seizures | 1 | 2022 | 3000 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1989 | 199 | 0.020 |
Why?
|
| Vaccines, Synthetic | 1 | 1992 | 622 | 0.020 |
Why?
|
| Pain | 2 | 2018 | 5100 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 20245 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 6131 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1993 | 2749 | 0.020 |
Why?
|
| Acids | 1 | 2009 | 125 | 0.020 |
Why?
|
| Genotype | 1 | 2023 | 13048 | 0.020 |
Why?
|
| Gene Expression | 2 | 2005 | 7603 | 0.020 |
Why?
|
| Prevalence | 1 | 2006 | 15879 | 0.020 |
Why?
|
| Morphogenesis | 1 | 1992 | 747 | 0.020 |
Why?
|
| Methylation | 1 | 1991 | 1078 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1989 | 1305 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2000 | 9565 | 0.020 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1989 | 446 | 0.020 |
Why?
|
| Erythema | 1 | 2009 | 261 | 0.020 |
Why?
|
| Antibody Formation | 1 | 1992 | 1393 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1989 | 828 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 1999 | 5151 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 1999 | 4207 | 0.020 |
Why?
|
| Absenteeism | 1 | 2008 | 247 | 0.020 |
Why?
|
| Immunoblotting | 1 | 1989 | 1647 | 0.020 |
Why?
|
| Molecular Structure | 1 | 1990 | 1885 | 0.020 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2005 | 68 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1987 | 513 | 0.020 |
Why?
|
| Flagellin | 1 | 2006 | 124 | 0.020 |
Why?
|
| Vaccination | 2 | 1995 | 3438 | 0.020 |
Why?
|
| Polydeoxyribonucleotides | 1 | 2006 | 136 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1989 | 2474 | 0.020 |
Why?
|
| Drug Costs | 1 | 1993 | 1198 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2006 | 706 | 0.010 |
Why?
|
| Boston | 2 | 2015 | 9377 | 0.010 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2005 | 148 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 2 | 2005 | 4785 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1991 | 4124 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2001 | 11932 | 0.010 |
Why?
|
| Hypotension | 1 | 2009 | 888 | 0.010 |
Why?
|
| Health Services | 1 | 2008 | 755 | 0.010 |
Why?
|
| Patients | 1 | 1989 | 908 | 0.010 |
Why?
|
| Caspases | 1 | 2005 | 881 | 0.010 |
Why?
|
| Nasopharynx | 1 | 2005 | 420 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2015 | 10115 | 0.010 |
Why?
|
| Critical Care | 1 | 2015 | 2716 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1987 | 3057 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 2003 | 244 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2009 | 1408 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2003 | 915 | 0.010 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1992 | 1520 | 0.010 |
Why?
|
| Cesarean Section | 1 | 1990 | 1426 | 0.010 |
Why?
|
| Soft Tissue Infections | 1 | 2003 | 168 | 0.010 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2003 | 348 | 0.010 |
Why?
|
| Models, Biological | 1 | 1997 | 9499 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2005 | 1526 | 0.010 |
Why?
|
| Dihydroalprenolol | 1 | 1979 | 8 | 0.010 |
Why?
|
| Rana pipiens | 1 | 1979 | 64 | 0.010 |
Why?
|
| Anura | 1 | 1979 | 79 | 0.010 |
Why?
|
| Guanine Nucleotides | 1 | 1979 | 55 | 0.010 |
Why?
|
| Rats | 2 | 1993 | 23786 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2003 | 587 | 0.010 |
Why?
|
| Cricetinae | 1 | 2003 | 2423 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1979 | 398 | 0.010 |
Why?
|
| Species Specificity | 1 | 2002 | 2417 | 0.010 |
Why?
|
| Precipitin Tests | 2 | 1991 | 816 | 0.010 |
Why?
|
| Erythrocyte Membrane | 1 | 1979 | 438 | 0.010 |
Why?
|
| United States | 1 | 2006 | 73186 | 0.010 |
Why?
|
| Pregnancy | 2 | 1999 | 30265 | 0.010 |
Why?
|
| Inpatients | 1 | 1989 | 2569 | 0.010 |
Why?
|
| Biological Evolution | 1 | 2002 | 1077 | 0.010 |
Why?
|
| Transformation, Bacterial | 1 | 1996 | 79 | 0.010 |
Why?
|
| Immunotherapy | 1 | 1992 | 4756 | 0.010 |
Why?
|
| Hospitals | 1 | 1988 | 3904 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1996 | 1065 | 0.010 |
Why?
|
| Safety | 1 | 1999 | 1161 | 0.010 |
Why?
|
| Hospital Bed Capacity, 300 to 499 | 1 | 1993 | 55 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1979 | 1243 | 0.010 |
Why?
|
| Tobramycin | 1 | 1993 | 65 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 1998 | 59739 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 1996 | 992 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1996 | 1356 | 0.010 |
Why?
|
| Forms and Records Control | 1 | 1993 | 158 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2015 | 42683 | 0.010 |
Why?
|
| Rhamnose | 1 | 1991 | 18 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1996 | 1528 | 0.010 |
Why?
|
| Health Services Misuse | 1 | 1993 | 249 | 0.010 |
Why?
|
| Hemolysin Proteins | 1 | 1990 | 113 | 0.010 |
Why?
|
| Penicillins | 1 | 1992 | 406 | 0.000 |
Why?
|
| Sepsis | 1 | 2003 | 2610 | 0.000 |
Why?
|
| Drug Information Services | 1 | 1988 | 51 | 0.000 |
Why?
|
| Hospitals, Teaching | 1 | 1993 | 1159 | 0.000 |
Why?
|
| Vaccines | 1 | 1996 | 843 | 0.000 |
Why?
|
| Cefazolin | 1 | 1988 | 95 | 0.000 |
Why?
|
| Education, Medical, Continuing | 1 | 1993 | 829 | 0.000 |
Why?
|
| Information Systems | 1 | 1989 | 400 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1987 | 455 | 0.000 |
Why?
|
| Metronidazole | 1 | 1988 | 236 | 0.000 |
Why?
|
| Clone Cells | 1 | 1990 | 1670 | 0.000 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1987 | 1057 | 0.000 |
Why?
|
| Chemical Precipitation | 1 | 1985 | 175 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2015 | 81903 | 0.000 |
Why?
|
| Cost Control | 1 | 1988 | 627 | 0.000 |
Why?
|
| Middle Aged | 2 | 1998 | 223737 | 0.000 |
Why?
|
| Aged | 1 | 1998 | 171786 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 20776 | 0.000 |
Why?
|
| Fever | 1 | 1989 | 1619 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1989 | 4862 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1989 | 6320 | 0.000 |
Why?
|
| Prognosis | 1 | 1989 | 30046 | 0.000 |
Why?
|